CYCN
Cyclerion Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.45
+0.03 ▲ +2.11%
🌙 3월 13일 5:00 PM ET (한국 3/14 06:00)
$1.39
-0.06 ▼ -4.10%
| Index | - | P/E | - | EPS (ttm) | -0.76 | Insider Own | 30.84% | Shs Outstand | 0.00B | Perf Week | 2.84% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | 18.85% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 5.02% | Short Float | 3.49% | Perf Quarter | -15.7% |
| Income | -0.00B | P/S | 2 | EPS this Y | - | Inst Trans | 1.88% | Short Ratio | 0.06 | Perf Half Y | -43.14% |
| Sales | 0.00B | P/B | 0.56 | EPS next 5Y | 59.52% | ROA | -22.77% | Short Interest | 0.09M | Perf YTD | 14.17% |
| Book/sh | 2.58 | P/C | 1.25 | EPS past 3/5Y | 64.17% 57.72% | ROE | -24.8% | 52W High | -61.74% ($3.79) | Perf Year | -41.3% |
| Cash/sh | 1.16 | P/FCF | - | Sales past 3/5Y | -20.24% -15% | ROIC | -23.06% | 52W Low | 41.24% ($1.03) | Perf 3Y | -87.72% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 64.13% | Gross Margin | - | Volatility(W/M) | 8.07% 8.74% | Perf 5Y | -98.3% |
| Dividend TTM | - | EV/Sales | 0.39 | Sales Y/Y TTM | 1371.65% | Oper. Margin | -127.25% | ATR (14) | 0.12 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.78 | EPS Q/Q | -5.73% | Profit Margin | -77.02% | RSI (14) | 57.52 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.78 | Sales Q/Q | 351.03% | SMA20 | 6.46% ($1.36) | Beta | 0.97 | Target Price | $8 |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | 4.12% ($1.39) | Rel Volume | 0.01 | Prev Close | $1.42 |
| Employees | 1 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -31.88% ($2.13) | Avg Volume(3M) | 1.53M | Price | $1.45 |
| IPO | 2019/3/18 | Option/Short | No/Yes | Trades | 167 | Volume | 18,850 | Change | 2.11% |
뉴스 로딩 중...